GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the human carboxypeptidase A1 in complex with a thiirane mechanism-based inhibitor

Analyse Crystal structure of the human carboxypeptidase A1 in complex with a thiirane… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4UF4
Type
protein
Length
788 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carboxypeptidase A1
EC
3.4.17.1
UniProt
P15085
Ligands
O2V, ZN
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarboxypeptidase A1 (EC 3.4.17.1)protein39640% helix, 18% strandP15085
BCarboxypeptidase A1 (EC 3.4.17.1)protein39238% helix, 19% strandP15085

Ligands and binding sites

  • O2V · (2S)-4-methyl-2-[(1R)-1-sulfanylethyl] pentanoic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15070.740.8367O2V
2630.710.9722O2V
34070.680.8145empty
43150.590.7744empty
51170.370.7420empty

Interfaces

1 interface between chains.

  • A–B · 485 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 disulfide (covalent ligand, disulfide).

Compared structures

  • P15085 · AlphaFold monomer V2.0 prediction for carboxypeptidase A1 (P15085) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.